1. OrthoPediatrics’ subsidiary, Telos Partners, hired Scott Day as senior vice president and general manager.
2. RTI Surgical is splitting its company into independent entities focused on surgical implants and biologics.
3. Abbott’s Proclaim XR spinal cord stimulation system was approved by the FDA for expanded MRI compatibility.
4. NuVasive’s Attrax Putty has been cleared by the FDA for use in interbody fusions of the thoracolumbar spine.
5. Surgalign Holdings acquired equity interest in Interneural Networks, whose artificial intelligence technology identifies possible pathological states.
